Source: Benzinga

Seraphina: Genova Diagnostics Launches At-home Fatty15 Test

Genova Diagnostics, a pioneer in gut health and nutritional laboratory testing, proudly announces the launch of the Fatty15 Test, in collaboration with Seraphina Therapeutics. This unique offering assesses pentadecanoic acid (C15:0), a newly established essential fatty acid.

Read full article »

Seraphina's Competitors | Seraphina's News | Seraphina's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

Co-Founder

Eric Venn-Watson

CEO Approval Rating

90/100

Seraphina is a California-based health and wellness company that develops and commercializes fatty acid supplements, food fortifiers and nutritional interventions.